Daniel S. Lorrain, Chief Scientific Officer at Contineum Therapeutics, Inc. (CTNM), sold 8,340 shares at $10.35 ($87K) on 2026-01-05, disclosed to the SEC on 2026-01-06.
Open-market sale of $87k CTNM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.35 | 3,670 | $38K | 43.6% |
| 2 | $10.35 | 3,670 | $38K | 43.6% |
| 3 | $11.13 | 500 | $6K | 6.4% |
| 4 | $11.13 | 500 | $6K | 6.4% |
| Total | $10.44 avg | 8,340 | $87K | 100% |
| Filing → |
| CTNM | SELL | 2026-06-01 | $55K | — | Filing → |
| CTNM | SELL | 2026-05-01 | $55K | — | Filing → |
| CTNM | SELL | 2026-04-06 | $56K | — | Filing → |